Zurich Cantonal Bank’s KalVista Pharmaceuticals KALV Stock Holding History

Zurich Cantonal Bank’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,868	Closed	-$289K	–	3043
2025 Q4	$289K	Buy	+17,868	New	+$237K	﹤0.01%	2077

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Zurich Cantonal Bank's KALV Position: Q2 2026 in Review

Zurich Cantonal Bank sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 24,296 shares — an estimated $489K sold.

Zurich Cantonal Bank first reported a position in KALV in Q1 2021 and held it in 10 quarters. The position peaked at $489K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Zurich Cantonal Bank reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Zurich Cantonal Bank sold 24,296 KalVista Pharmaceuticals shares in Q2 2026, an estimated $489K.
Zurich Cantonal Bank first reported a position in KalVista Pharmaceuticals in Q1 2021 and held it in 10 quarters.
Zurich Cantonal Bank's KalVista Pharmaceuticals position peaked at $489K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.